home / stock / bsem / bsem news

BSEM News and Press, BioStem Technologies Inc From 02/12/24

Stock Information
Company Name: BioStem Technologies Inc
Stock Symbol: BSEM
Market: OTC
Website: biostemtechnologies.com
Menu
BSEM BSEM Quote BSEM Short BSEM News BSEM Articles BSEM Message Board
Get BSEM Alerts

News, Short Squeeze, Breakout and More Instantly...
BSEM - Expected US Company Earnings on Monday, February 12th, 2024

Verde Clean Fuels Inc. (VGAS) is expected to report for Q4 2023 Pioneer Bancorp Inc. (PBFS) is expected to report for Q2 2024 Equity Commonwealth of Beneficial Interest (EQC) is expected to report $0.27 for Q4 2023 monday.com Ltd. (MNDY) is expected to report $-0.31 for Q4 2023 As...
BSEM - Expected earnings - BioStem Technologies Inc

BioStem Technologies Inc (BSEM) is expected to report $0.47 for Q4 2023

BSEM - Amniowrap2(TM) Product Launch Leads Year of Highlights for BioStem Technologies

BioStem provides a business update and highlights recent accomplishments Preliminary fourth quarter net revenues of $11.5 million and full year 2023 net revenues of $16.7 million National Pricing for Amniowrap2™ effective January 1 st in all 50 states and territories POMP...

BSEM - BioStem Technologies Appoints Proven Life Science Sales Leader Shawn McCarrey to Chief Commercial Officer Role

POMPANO BEACH, Fla., Jan. 11, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc . (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces it has appointed a ...
BSEM - BioStem Technologies Appoints Executive Leader Patrick Daly to Board of Directors

POMPANO BEACH, Fla., Dec. 19, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc . (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces it has appointed Mr...

BSEM - Center for Medicare Services Established National Pricing of AmnioWrap2(TM) in All MAC Regions

POMPANO BEACH, Fla., Dec. 14, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics for advanced wound care, announced that the Center for Medicare Servi...

BSEM - BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors

POMPANO BEACH, Fla., Dec. 13, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc . (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces the appointment of M...
BSEM - BioStem Technologies GAAP EPS of $0.03, revenue of $3.6M

2023-11-14 10:58:43 ET BioStem Technologies press release ( OTCPK:BSEM ): Q3 GAAP EPS of $0.03. Revenue of $3.6M (+227.3% Y/Y). For further details see: BioStem Technologies GAAP EPS of $0.03, revenue of $3.6M

BSEM - BioStem Technologies Reports Third Quarter 2023 Operating and Financial Results

POMPANO BEACH, Fla., Nov. 13, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today reported financial results for the quarter ended September 30,...

BSEM - BioStem Technologies Awarded Q Code for VENDAJE AC® Line from Centers for Medicare and Medicaid Services

POMPANO BEACH, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc . (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture and commercialization of placental-derived biologics for advanced wound care, today announced that the Centers for ...
Previous 10 Next 10